Tilray® receives approvals to expand and commercialize medical cannabis products in new zealand

Nanaimo, british columbia--(business wire)--tilray, inc. (nasdaq: tlry), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that it has received the necessary approvals from new zealand's ministry of health and the medicinal cannabis agency to launch tilray medical cannabis products across the country. tilray is one of the leading providers of medical cannabis in australia and new zealand for commercial, compassionate access, and research purposes
TLRY Ratings Summary
TLRY Quant Ranking